ライフサイエンスコーパス: be treated with

1 the effects of chitosan in mango fruits, it was treated with 0%, 1%, 2% or 3% of chitosan solutions,

2 Serum and whole-blood samples were treated with 0.1% or 1% sodium dodecyl sulfate (SDS

3 reated with 10 mg/kg SB431542 and all wounds were treated with 0.5% PVI for 5 days.

4 cyclopropanes or corresponding cyclobutanes were treated with 1,3,5-triazinanes, leading to the five

5 Patients in the expansion cohort were treated with 1.0 mg/kg luspatercept; dose titration

6 Patients were treated with 10 g of brimonidine, 0.33%, gel applie

7 ally well regardless of whether patients had been treated with (131)I previously or had abnormal rena

8 e men, with a total testosterone <12 nmol/L, were treated with 15 g soy protein containing 66 mg of i

9 eptozotocin-induced diabetic rats (STZ-rats) were treated with 15 mug/kg GHRH agonist, MR-409, or GHR

10 Onion juice was treated with 2,4-dinitrophenylhydrazine to obtain hy

11 P-UAECs were treated with 2-OHE2 and 4-OHE2 for 0, 0.25, 0.5, 1,

12 All patients were treated with 200 mg intravenous pembrolizumab every

13 asurable metastatic lesion in the liver that was treated with 3 cycles of anthracycline-based chemoth

14 revent non-specific binding the gold surface was treated with 3% BSA before detection.

15 They were treated with 3-drug induction chemotherapy (vincris

16 Of 482 patients, 53% were treated with 3D-CRT and 47% with IMRT.

17 Cells were treated with 5% CS extract (CSE) for various period

18 Fellow eyes (n = 207) were treated with 5-minute dosing and considered in the

19 ith an anti-CD20 antibody-containing regimen were treated with 560 mg ibrutinib orally once daily unt

20 Although both conditions are treated with a gluten-free diet, distinguishing betw

21 ute hepatitis C virus (HCV) infection should be treated with a combination of sofosbuvir and an NS5A

22 s indicate that a proportion of patients may be treated with a minimal amount of intervention requiri

23 15) who had craniospinal irradiation and had been treated with a curative intent.

24 7%]), 98 had panic disorder, 252 had GAD, 67 were treated with a benzodiazepine, and 293 were treated

25 his phenomenon was corroborated when WT mice were treated with a CB2-specific antagonist that caused

26 patient-derived tumor xenografts (PDXs) that were treated with a direct inhibitor of the kinase ERK,

27 patients with an established diagnosis of FD were treated with a fixed combination of pepsin and amin

28 d 33%, respectively in chickpea sprouts that were treated with a high sodium selenite content (2mg/10

29 All patients were treated with a mean of 6 GBq.

30 evere degenerative mitral regurgitation (MR) were treated with a mitral valve repair system (MVRS) vi

31 perinfection was observed even when the mice were treated with a monoclonal antibody to eliminate res

32 atients with penicillin-susceptible isolates were treated with a penicillin family antimicrobial.

33 atients had a clinical diagnosis of CALM and were treated with a Q-switched or picosecond laser.

34 were treated with a benzodiazepine, and 293 were treated with a serotonin reuptake inhibitor during

35 Patients were treated with a single 8-Gy radiotherapy dose for 1

36 Patients were treated with a single fraction of 25 Gy while awake

37 Mice were treated with a single injection (10 mg/kg) of PLP-L

38 n four study groups of six animals per group were treated with (a) combination therapy of magnetic re

39 intraportal islet transplantation when they were treated with AAT compared with mice treated with sa

40 , 15.2% squamous cell carcinoma), 335 (9.3%) were treated with AC.

41 When mouse xenografts were treated with adenoviruses and ganciclovir, all anim

42 t controlled with the maximum dose of opioid were treated with adjunctive phenobarbital.

43 en receptor (ERalpha)-positive breast cancer are treated with adjuvant endocrine therapy, including s

44 ents with high-risk histopathologic features were treated with adjuvant chemotherapy, and no metastas

45 ere treated with ADT plus docetaxel, and 361 were treated with ADT alone.

46 ents were eligible for this subanalysis; 358 were treated with ADT plus docetaxel, and 361 were treat

47 Four-day-old male mice were treated with AFB1 using a regimen that induced HCC

48 who are still at high risk of stroke despite being treated with aggressive medical management.

49 o develop this approach, melanoma cell lines were treated with AKT inhibitor AZD5363 [4-amino-N-[(1S)

50 Rabbits were treated with alloxan to destroy pancreatic islet ce

51 To assess TH involvement, Wistar rats were treated with alpha-methyl-L-tyrosine and tyrosol.

52 Because more patients are being treated with alternative programs, comparison of r

53 re (86% vs 32%, p<0.001), and more likely to be treated with amphotericin B (AmB) (87% vs 24%, p<0.00

54 th cALD and early-stage cerebral disease who were treated with an allogeneic HSCT and to identify dis

55 n vitro fibrin clots and rats with aortic EE were treated with an antipseudomonas phage cocktail alon

56 HUVECs were treated with and without palmitate in the presence

57 cells (HUVECs) grown in microfluidic devices were treated with Angiopoietin 1 and cyclic adenosine mo

58 cardiovascular risk factor; 92% of survivors were treated with anthracycline-containing regimens.

59 expresses the estrogen receptor (ER(+)) and is treated with anti-estrogen therapies, particularly ta

60 L2-IL5(OXA) EoE mice were treated with anti-GM-CSF neutralizing antibody or i

61 ed by interactions with CD11c(+) cells, mice were treated with anti-LFA-1 Abs to reduce the number of

62 ts with sarcoidosis and skin involvement who were treated with anti-TNF were included, median (range)

63 Patients were treated with antiarrhythmic drugs (most commonly am

64 is and encephalitis in the United States and are treated with antibiotic therapy in the majority of c

65 ) for depression and another 6,068 (13%) had been treated with antidepressants.

66 tected by rapid diagnostic testing (RDT) who were treated with antimalarials (n = 104), (2) RDT-negat

67 a new diagnosis of advanced-stage NSCLC and were treated with antineoplastic agents between 2000 and

68 with human immunodeficiency virus (HIV) that is treated with antiretroviral therapy have improved lon

69 Patients were treated with aspirin and clopidogrel for the entire

70 cate clinical therapy, osteonecrotic defects were treated with autologous bone graft, which were simu

71 Results Forty-four patients were treated with avelumab and followed for a median of

72 A total of 132 lesions were treated, with average 1.4 lesions per patient treat

73 on, orthopnea, diabetes mellitus and anemia, be treated with beta-blockers, have higher ejection frac

74 The patients were treated with bilateral orchiectomy or GnRHa therapy

75 who have evidence of bone metastases should be treated with BMAs.

76 patients diagnosed with uveal melanoma, 311 were treated with brachytherapy.

77 iously experienced disease progression while being treated with brentuximab.

78 C cells (MDA-MB-157, MDA-MB-231, and Hs578T) were treated with bromodomain-containing protein 4 (BRD4

79 rticipants with single Miller Class I/II GRs were treated with CAF (n = 17), CAF + CM (n = 17), CAF +

80 a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists.

81 Mice were treated with carbon tetrachloride (CCl4) or with ve

82 on in the present subsample should therefore be treated with caution.

83 All, or one, out of 11 steers were treated with CCFA on day 0 in 8 pens, with half of

84 ess cost when 31% (95% CrI 26%-36%) of cases were treated with cefixime, and when more than 55% (95%

85 hen more than 55% (95% CrI 44%-66%) of cases were treated with cefixime, the resistant strain had a n

86 bapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed.

87 kinin 1 receptor antagonists in patients who are treated with chemotherapy.

88 mary malignancy at age 70 years or older and were treated with chemotherapy but did not develop thera

89 d postrandomization expectancy, participants were treated with citalopram or placebo for 8 weeks.

90 Patients were treated with clobetasol ointment and intralesional

91 ctrometry suggested that Stradivari's maples were treated with complex mineral preservatives containi

92 A total of 83 (64%) of these eyes were treated with concomitant ophthalmic artery chemosur

93 sterior and panuveitides requiring treatment are treated with corticosteroids and immunosuppression.

94 When seabass skin was treated with crude lipase from seabass liver at vari

95 CV infection after liver transplantation who were treated with DAAs, with or without ribavirin, from

96 Patients being treated with darunavir, or who had homozygous fami

97 A patient with refractory T-ALL was treated with dasatinib on the basis of drug profilin

98 se concentration of 7.8-22.2 mmol/L who were being treated with diet or oral antidiabetic drugs or ha

99 tumor microenvironment of patients who have been treated with different immune checkpoint modulators

100 LMCs were treated with different concentrations of insulin or

101 thout predosing with 40 mg of lilotomab) and were treated with different levels of activity per body

102 Sequentially, the quaternary ammonium salts were treated with different nucleophiles for performing

103 oderate to severe acute migraine attacks can be treated with dihydroergotamine mesylate (DHE), an erg

104 hen spontaneous seizures were frequent, mice were treated with diphtheria toxin to ablate peri-insult

105 The effect was reversed in cells that were treated with DPP4 inhibitor along with pro-CD.

106 acylation was abolished when the Wnt peptide was treated with DTT, and did not occur with a linear (n

107 1a male post-LT patients on hemodialysis who were treated with EBR/GZR with or without ribavirin for

108 meningococcal disease in immunized patients being treated with eculizumab and suggest that vaccinati

109 venty-two mandibular molar furcation defects were treated with either access therapy alone (group 1),

110 key heterotopic cardiac allograft recipients were treated with either IDEC-131 (humanized alphaCD154,

111 Sham-surgery and SCNX mice were treated with either Meth (1.2 mg/kg, i.p.) or vehic

112 s in 15 NCr nude immunodeficient mice, which were treated with either the cytotoxic drug, Irinotecan,

113 type II collagen/CFA to induce arthritis and were treated with either the stimulatory mAb to LAIR-1 o

114 is used to determine whether patients should be treated with endocrine therapy, which is designed to

115 Patients and Methods Adult patients were treated with escalating dosages of BGJ398 5 to 150

116 seventy patients were included, of whom 4039 were treated with EVAR and 1131 with OSR.

117 Twenty-eight patients were treated with every-2-week dosing (n = 10 at 0.6 mg/

118 ose Men with localized prostate cancer often are treated with external radiotherapy (RT) over 8 to 9

119 One hundred five consecutive patients who were treated with extracorporeal membrane oxygenation fr

120 ted with gingival recession (GR) at baseline were treated with FGGs in a private practice.

121 In this study, DPCs were treated with fibroblast growth factor-2 (FGF2) for

122 in the presence and absence of pentobarbital were treated with fluorescently-labeled, hydroxyl-functi

123 Severely asthmatic horses (6 horses/group) were treated with fluticasone, salmeterol, fluticasone/s

124 74 of 195 (38.0%) patients; 35 of 74 (47.3%) were treated with fondaparinux.

125 tients with treatment-naive, clear cell mRCC were treated with four cycles of sunitinib (50 mg once p

126 unresponsive to immunosuppression reduction, were treated with four weekly doses of rituximab inducti

127 disease phenotypes, 12-month-old Fabry mice were treated with gene transfer-mediated ERT or substrat

128 n intact and MDFIC-deficient A549 cells that were treated with glucocorticoids.

129 nts with different liver disease stages have been treated with great success including those awaiting

130 nts with confirmed or suspected botulism who were treated with HBAT under an expanded-access Investig

131 Most of them can be treated with hearing aids.

132 ikelihood of nausea among adult patients who are treated with high emetic risk antineoplastic agents.

133 umorigenicity-2 between matched patients who were treated with high-flow nasal cannula and those who

134 d, 127 (74.7%) were intubated and 43 (25.3%) were treated with high-flow nasal cannula at acute respi

135 14-2.80], respectively) whereas patients who were treated with higher MR antagonist doses and had uns

136 SF and peripheral blood (PB) CD14+ monocytes were treated with histamine, IL-17, IL-21 and IL-22, and

137 ote macrophage activation, THP-1 macrophages were treated with HMEC-conditioned medium (CM).

138 In the presented study, DHNQ was treated with hydrogen peroxide under alkaline condit

139 All patients were treated with I-125 brachytherapy, and 2 received as

140 ients included in the analysis, 102 patients were treated with IB (IB group) and 73 patients were tre

141 Forty patients with recurrent FL were treated with ibrutinib 560 mg/d until progression o

142 pertrophy in vitro Primary skeletal myotubes were treated with IGF-1 (50 ng/ml) with or without 0.5 m

143 ide insight into why patients with arthritis being treated with IL-6 inhibitors develop new onset pso

144 lin was bound to EHD2 protein and when cells were treated with IL-6, myoferlin dissociated from EHD2

145 years of follow-up in patients with CML who were treated with imatinib as initial therapy.

146 Transplant recipients are treated with immunosuppressive (IS) therapies, which

147 which partitions it to a different location, were treated with infectious, misfolded forms of the pri

148 rrhotic bile duct ligated (BDL) rats with PH were treated with Infliximab (IFX, a monoclonal antibody

149 Human TNF transgenic (hTNF-Tg) mice were treated with infliximab after development of arthri

150 we recruited 115 stable asthmatics that were being treated with inhaled corticosteroids at the time o

151 T cell proliferation was restored when MDSC were treated with inhibitors of inducible nitric oxide s

152 All 4 patients were treated with injection of intravitreous vancomycin

153 did not receive any antiviral treatment, 38% were treated with interferon alfa (IFNalpha)-based thera

154 A total of 16 901 ischemic stroke patients were treated with intravenous tPA within 4.5 hours of sy

155 The patient was treated with intravitreal triamcinolone (0.1 mL/4 mg

156 with proliferative diabetic retinopathy who were treated with intravitreal aflibercept had an improv

157 signed to ipilimumab and 202 to placebo; 399 were treated with ipilimumab and 199 with placebo.

158 IDA patients can be treated with iron supplementation, yet TT patients ha

159 with only or over 99% expression of InsP3R-1 were treated with isoflurane or propofol.

160 Patients were treated with IVT with tissue plasminogen activator

161 horium complex [(C5Me5)2ThMe][BPh4] that can be treated with KC5Me5 to generate (C5Me5)3ThMe, 1.

162 5Pbeta6 experimental metastatic lung tumours were treated with L-ALD or t-L-ALD as monotherapies or i

163 unity composition regardless of whether they were treated with L. reuteri or treated with vehicle as

164 ial of laropiprant, WT mice subjected to ICH were treated with laropiprant at 1 hour after the ICH.

165 All patients were treated with ledipasvir-sofosbuvir (90 mg and 400 m

166 ldren with moderate acute malnutrition (MAM) are treated with lipid-based nutrient supplement (LNS) o

167 Mice were treated with lipopolysaccharide or hydrochloric aci

168 C (median age, 58 years; range, 37-79 years) were treated with liposomal doxorubicin, bevacizumab, an

169 calvarial model, Mk2(+/+) and Mk2(-/-) mice were treated with live A. actinomycetemcomitans bacteria

170 hort of women 40 years or older, all of whom were treated with long-acting (glargine, detemir) or neu

171 Young (3-month-old) mice were treated with losartan ( approximately 10 mg/kg/d, 4

172 Each patient was treated with low-dose naltrexone hydrochloride at a

173 METHODS AND Human hepatoma cells were treated with Lp(a) purified from human plasma and L

174 2c, and </= 10 pack-year smoking history who were treated with </= 54 Gy of radiation (n = 27).

175 o 1.75 mg/kg was allowed, and patients could be treated with luspatercept for a maximum of 5 years.

176 Patients were treated with lymphodepleting conditioning chemother

177 Recipients were treated with lytic IL-2/Fc, nonlytic IL-2/Fc, TGF-b

178 eatic CSC was observed when MIA PaCa-2 cells were treated with MDB5 compared to GDC-0449.

179 olism were compared among eight patients who were treated with methotrexate and eight untreated age-m

180 fy 25 629 individuals aged 6 to 25 years who were treated with methylphenidate between January 1, 200

181 The control group was treated with MI and given oral hygiene instructions.

182 Globally, most patients with hypertension are treated with monotherapy, and control rates are poor

183 The control group was treated with nadolol+nitrates+ligation.

184 In the HVPG-guided group, acute responders were treated with nadolol and acute nonresponders with n

185 All patients were treated with nCRT (carboplatin/paclitaxel/41.4 Gy)

186 Moreover, rats were treated with necrostatin-1, an inhibitor of program

187 Patients were treated with neoadjuvant chemotherapy, transthoraci

188 born with birth weight less than 1,251 g who were treated with neonatal caffeine had improved respira

189 ses that overlap with or mimic GERD can also be treated with neuromodulators (primarily antidepressan

190 ormal cell BEAS2B and lung cancer cell lines was treated with nicotine and the results showed nicotin

191 ontaneous urticaria (CSU) patients (n = 113) were treated with omalizumab 300 mg/4 weeks for 12 weeks

192 a significant response to allergen challenge were treated with omalizumab according to the approved d

193 egion, the dorsal caudate, patients with FEP were treated with oral risperidone for 4 weeks at an ini

194 g cancer and the EGFR Thr790Met mutation who were treated with osimertinib, a third-generation EGFR T

195 The majority of cases were treated with other beta-lactams, trimethoprim-sulfa

196 All cases were treated with pars plana vitrectomy (PPV) and a doub

197 vs 0.223 g +/- 0.112, respectively; six mice were treated with pazopanib and seven were control mice;

198 Eleven women were treated with pdC1-INH for 143 facial attacks.

199 Whole oca tubers were treated with PEF at different electric field streng

200 60 Patients with GT-1 CHC infection who had been treated with PegIFN/RBV were enrolled, including 27

201 ntal delay in expression of the UGT1A1 gene, were treated with PEITC, TSB levels were reduced.

202 In 1 patient with locally advanced cSCC who was treated with pembrolizumab, nearly complete tumor re

203 Methods Patients were treated with pembrolizumab 10 mg/kg every 2 weeks f

204 roducing Enterobacteriaceae generally cannot be treated with penicillins and cephalosporins.

205 Specifically, aldehydes are treated with pentafluoropropen-2-olate, generated fr

206 to 547 patients receiving prednisolone; 546 were treated with pentoxifylline.

207 Papers and textiles that are treated with per- and polyfluoroalkyl substances (PF

208 in patients with NSTEMI, whether or not they were treated with percutaneous coronary intervention.

209 ort, primary adult mouse DRG neuron cultures were treated with physiologic concentrations of palmitat

210 ean samples (red kidney bean and white bean) were treated with phytase.

211 of these proteins was restored in cells that were treated with pioglitazone, a PPARgamma agonist, bef

212 ipants with peanut allergy (ages 4-25 years) were treated with placebo (n = 25), Viaskin Peanut 100 m

213 astatic castration-resistant prostate cancer were treated with placebo alone.

214 ata from 813 patients with schizophrenia who were treated with placebo in 12 randomized placebo-contr

215 sequential IAV infections, adult female mice were treated with placebo or one of two progestins, P4 o

216 al time in 56 patients with glioblastoma who were treated with postoperative concurrent radiation and

217 Patients were treated with pralatrexate (10 to 25 mg/m(2)) and ro

218 dose (n = 1) and higher-dose (n = 2) cohorts were treated with prednisolone.

219 ly advanced (cT3-4 or cN+) rectal cancer who were treated with preoperative chemoradiotherapy followe

220 Chardonnay grape pomace was treated with pressurized heat followed by enzymatic

221 Squamous cancers can be treated with primary chemoradiotherapy without surger

222 Cocultured cells that were treated with pro-CD demonstrated a significant decr

223 Human endothelial and smooth muscle cells were treated with pro-inflammatory cytokines with or wit

224 Nine infants with periocular IH were treated with propranolol (oral) for 2-12 months (me

225 ic reassessment performed in 35 patients who were treated with pulmonary arterial hypertension-target

226 The cultures of Saccharomyces cerevisiae were treated with pulsed electric fields (PEF) in order

227 The mono- and diformylated azaBODIPYs were treated with pyrrole under mild acidic conditions f

228 Twenty-seven patients were treated with R-CHOP with an overall response rate o

229 eeds after intravitreal injection and no eye was treated with radiation or enucleated for seeding.

230 Overall, 936 patients were treated with ranibizumab, 0.5 mg; 250 patients with

231 When Tm infected mice were treated with rapamycin, DCLK1 and IL-25 expression

232 ized metal complexes on metal oxide surfaces are treated with reactive metal reagents in the gas phas

233 th increased when zebrafish single cell RGCs were treated with receptor-type-specific antagonists and

234 n this study, newborn CBS-knockout (KO) mice were treated with recombinant polyethyleneglycolylated h

235 trally reviewed patients with stage III FHWT were treated with Regimen DD4A and radiation therapy.

236 tients with isoniazid-resistant tuberculosis were treated with regimens containing rifampin, pyrazina

237 ich patients and families in the ICU setting are treated with respect and dignity.

238 -risk patients did not differ much when they were treated with rFVIII (43% and 47%, respectively).

239 rt of 84 patients with biopsy-proven HIV+MCD were treated with risk-stratified rituximab-based therap

240 sease and symptoms of agitation or psychosis were treated with risperidone for 16 weeks, after which

241 n a majority of AIR patients while they were being treated with rituximab.

242 The patients were treated with rituximab and followed up for 18 to 84

243 ts who had epitope spreading at baseline and were treated with rituximab showed reversal of epitope s

244 In the dose-expansion phase, patients were treated with selinexor at 35 or 60 mg/m(2) The most

245 enografted with the human NET cell line GOT1 were treated with semiefficient doses of (177)Lu-DOTATAT

246 lly, acute hepatitis C virus (HCV) infection was treated with shorter durations of interferon-contain

247 All participants were treated with single-dose azithromycin (30 mg/kg) an

248 work, 3xTg-AD mice in the early stage of AD were treated with SLAB51 probiotic formulation, thereby

249 When cells were treated with SMase, the binding of ALO-D4 to cells

250 In this study, humanized mice were treated with Smoothened Agonist (SAG), a Sonic Hedg

251 % GT1a, 27% GT1b, and 8% GT1 no subtype) and were treated with sofosbuvir (SOF)/ledipasvir +/- ribavi

252 Once colitis was established, mice were treated with solvent, EPO or the selective IRR agon

253 response affects 1% of patients with HCC who are treated with sorafenib.

254 Patients were treated with SRS followed by EGFR-TKI, WBRT followe

255 ived specimens of 5 patients with CM who had been treated with surgical excision between 2006 and 201

256 positive-biopsy patients were more likely to be treated with systemic immunosuppression and were foll

257 Most of the children were treated with systemic corticosteroids for many mont

258 Five patients (8%) were treated with systemic steroids for immune-related A

259 ause of cancer-related deaths in the US, has been treated with targeted therapies.

260 raction of hRXRalpha are restored when cells are treated with the MEK1/2 inhibitor UO126 or following

261 ening heparin-induced thrombocytopenia (HIT) is treated with the alternative nonheparin anticoagulant

262 Schistosomiasis is treated with the drug praziquantel (PZQ), which has p

263 Ar*=2,6-(2',4',6'-triisopropylphenyl)phenyl) was treated with the well-known frustrated Lewis pair (F

264 One hundred forty-eight eyes were treated with the accelerated protocol and 138 with

265 amous cell lung or head and neck cancers who were treated with the approved PD1-targeting antibodies

266 Animals were treated with the biochemical inhibitor (2 mg/Kg/day

267 dy, in which patients with EGFR-mutant NSCLC were treated with the combination of erlotinib and bevac

268 (12 teeth with artificially deeper pockets) were treated with the contrast agent, and the probing de

269 each study met criteria for switching, they were treated with the initial agent throughout the study

270 Six patients were treated with the initial weekly dosing scheme; 2 of

271 een subjects with cardiovascular dysfunction were treated with the interleukin-6 receptor antibody to

272 nts were assigned ASCT, and PET4(+) patients were treated with the investigator's choice.

273 tly increased when CML stem/progenitor cells were treated with the JAK1/2 inhibitor ruxolitinib (RUX)

274 s and severe TR on optimal medical treatment were treated with the MitraClip system.

275 of TLR expression was not evident when cells were treated with the neurokinin 1 receptor antagonist a

276 C57Bl/6 mice were treated with the NO synthase inhibitor L-N(G)-nitro

277 response, SJSA cells (shCDK19 versus shCTRL) were treated with the p53 activator nutlin-3.

278 FAH(-/-) pigs were treated with the protective drug 2-(2-nitro-4-trifl

279 ere followed for 1 y, and recurrent episodes were treated with the same treatment allocated at enrolm

280 The other half were treated with the traditional revascularization prot

281 om CD34(+) hematopoietic stem cells (CD34LC) were treated with the UV photoproduct and AhR ligand 6-f

282 IBC were included after matching (56 who had been treated with TMT, and 56 who underwent RC).

283 Mice carrying inflamed human arteries were treated with tofacitinib or vehicle.

284 included: 37 had parenteral ondansetron, 14 were treated with traditional therapy, and 15 did not re

285 Oat and faba bean protein isolates were treated with transglutaminase from Streptomyces mob

286 R2-positive breast cancer patients that have been treated with trastuzumab may experience a more robu

287 Prior to MSPE, the sample was treated with trichloroacetic acid, and the APs deriv

288 all amino acids and low amounts of thymidine were treated with trimethoprim under aerobic and anaerob

289 rse of the MLR, was further enhanced when DC were treated with TSLP plus ACh, instead of TSLP or ACh

290 rent red wines with reductive character have been treated with two different doses of copper sulfate

291 leukaemia; were aged 18 years or older; had been treated with two lines of therapy (with at least a

292 onic phase chronic myeloid leukemia (CP-CML) are treated with tyrosine kinase inhibitors (TKIs).

293 isease requiring staged procedure at 1 month were treated with Ultimaster.

294 Human retinal pigment epithelial cells were treated with various combinations of BEV and RES.

295 Studies in which cells were treated with varying concentrations of each isomer

296 n isolate (WPI) solutions (12.8%w/w protein) were treated with varying concentrations of H2O2 in the

297 Mice were treated with vehicle, FTY720, AAL(S) , BORT or AAL(

298 At baseline, 37,539 patients (52%) were treated with vitamin K antagonist (VKA) monotherapy

299 vel (CAL) after initial non-surgical therapy were treated with VMIS.

300 rgeted temperature management; of those, 110 were treated with volatile sedation using an anesthetic